Skip to main content
Clinical Trials/IRCT20220302054164N2
IRCT20220302054164N2
Not yet recruiting
Phase 3

The effect of intravenous infusion of remifentanil and dexmedetomidine on hemodynamic changes and pain in patients undergoing cataract surgery

Arak University of Medical Sciences0 sites122 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Arak University of Medical Sciences
Enrollment
122
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • All patients referred to Amirkabir Arak Hospital for cataract surgery
  • signing informed consent by patients
  • Patients age 25\-75 years
  • American Society of Anesthesiologists (ASA) physical status classification I \& II
  • Candidates of local anesthesia

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials